GlucoSentient, Inc.

Biotechnology ResearchIllinois, United States2-10 Employees

The Blood Glucose Meter (BGM) is a widely available and proven medical device that is used by millions of diabetics around the globe. Today’s glucose meter is the culmination of over 30 years of engineering and development efforts to make it do one thing extraordinarily well: measure blood glucose levels anytime, anywhere. At GlucoSentient, we have developed a powerful technology that is transforming the BGM into a device that is capable of quantitatively and conveniently detecting other non-glucose targets. This is made possible by our patent pending technology that translates the amount of non-glucose target to glucose. The amount of glucose is then measured by the BGM. The technology is robust and widely applicable, including heavy metal ions (environmental monitoring), small molecules (drug monitoring, drugs-of-abuse tests), protein markers (immunoassay diagnostics) and nucleic acid (molecular diagnostics) quantification.

Sign up for free to view info

Email Format Employee directory